BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24362487)

  • 1. Response: importance of screening for macroprolactin in hyperprolactinaemic sera.
    Jamaluddin FA
    Malays J Pathol; 2013 Dec; 35(2):190. PubMed ID: 24362487
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
    Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
    Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should macroprolactin be measured in all hyperprolactinaemic sera?
    McKenna TJ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroprolactin and hyperprolactinaemia.
    Wiwanitkit V
    Malays J Pathol; 2013 Dec; 35(2):189. PubMed ID: 24362486
    [No Abstract]   [Full Text] [Related]  

  • 5. Is polyethylene glycol precipitation of hyperprolactinaemic samples required when using the Beckman Coulter DxI-800 prolactin assay?
    Hawkins RC
    Clin Chem Lab Med; 2012 Feb; 50(4):757-9. PubMed ID: 22505565
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.
    Kavanagh-Wright L; Smith TP; Gibney J; McKenna TJ
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):599-605. PubMed ID: 18771565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of prolactin: the macroprolactin problem.
    Fahie-Wilson M; Smith TP
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
    Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with macroprolactinaemia: clinical and radiological features.
    Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
    Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinaemia caused by antipsychotic drugs: a new application for prolactin assays.
    Ellis A; Fahie-Wilson M
    Ann Clin Biochem; 2010 Jul; 47(Pt 4):287-9. PubMed ID: 20592330
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
    Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W
    Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactin and the laboratory].
    Veloza A; Prazeres S
    Acta Med Port; 2011 Dec; 24 Suppl 4():1029-34. PubMed ID: 22863514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of macroprolactin causing hyperprolactinemia in commercial assays for prolactin.
    Fahie-Wilson MN
    Clin Chem; 2000 Dec; 46(12):2022-3. PubMed ID: 11106347
    [No Abstract]   [Full Text] [Related]  

  • 16. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of macroprolactin on galactorrhea and the rate of patients possibly affected by macroprolactin.
    Aisaka K; Tsuchiya F; Sueta M; Itabashi K; Nose S; Hasegawa A; Obata S; Hiraike H; Yokoyama T
    Endocr J; 2018 Feb; 65(2):203-211. PubMed ID: 29162783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin.
    Byrne B; O'Shea P; Barrett P; Tormey W
    Clin Chem Lab Med; 2010 Feb; 48(2):205-8. PubMed ID: 19943807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant occurrence of macroprolactin, exercise-induced amenorrhea, and a pituitary lesion: a diagnostic pitfall. Case report.
    Cattaneo FA; Fahie-Wilson MN
    J Neurosurg; 2001 Aug; 95(2):334-7. PubMed ID: 11780906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and macroprolactin: a case report of hyperprolactinaemia highlighting the interpretation of discrepant results.
    Ismail AA; Walker PL; Fahie-Wilson MN; Jassam N; Barth JH
    Ann Clin Biochem; 2003 May; 40(Pt 3):298-300. PubMed ID: 12803849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.